Great discussions at #ASHG2026! 🧬 Our Alithea Genomics team joined our partners at Revvity to connect with researchers exploring the links between genetic variation, gene function, and disease mechanisms. #ASHG2026 #DRUGseq #Transcriptomics #DrugDiscovery

Can a multiplexed total RNA-seq workflow deliver the same biology as standard library prep kits? Our new tech note benchmarks MERCURIUS™ Total BRB-seq against NEBNext® and Watchmaker total RNA kits. Link: eu1.hubs.ly/H0zl_QC0 #RNAseq

4× the wells. But what happens to the data? Join Alithea + Nuvisan on Nov 10 for 384 vs. 1536-well DRUG-seq performance data, MoA signatures, and practical screening insights. Register: eu1.hubs.ly/H0zk3Y90 #DRUGseq #DrugDiscovery #Transcriptomics #HighThroughputScreening

Big questions in human genetics deserve powerful tools to answer them. 🧬 Meet Andrea and Daniela and explore how scalable, high-throughput transcriptomics can bring deeper biological insights to your research. #ASHG2026 #FunctionalGenomics #DrugDiscovery #RNAseq

Over 180 people have registered so far for this Wednesday's webinar titled: From Target Discovery to Toxicology. Register: eu1.hubs.ly/H0zbLJs0 #DrugDiscovery #CellPainting #Transcriptomics

We're hiring an NGS Specialist in the US! 📍 Frederick, MD, USA | Full-time, on-site Interested? Apply here: eu1.hubs.ly/H0y_RgB0 #NGS #RNAseq #Genomics #BiotechJobs

Join us at ELRIG Drug Discovery 2026! Our team will present three scientific posters exploring how high-throughput transcriptomics can advance compound screening, MoA studies, and toxicity assessment. #ELRIG2026 #DrugDiscovery #Transcriptomics #HighThroughputScreening

Join Alithea Genomics and Axxam to explore what Cell Painting and DRUG-seq each reveal through two case studies on target validation and toxicology. Register: eu1.hubs.ly/H0yTk0l0 #DrugDiscovery #CellPainting #Transcriptomics #Toxicology

Last chance to join our next webinar with Senior Data Scientist Alexandre Coudray, PhD, and learn the key steps of MERCURIUS™ DRUG-seq data analysis. 👉 Register here: eu1.hubs.ly/H0ygp4Y0 #Bioinformatics #DrugDiscovery #RNAseq

Join our upcoming webinar with Senior Data Scientist Alexandre Coudray, PhD. Learn the key steps of MERCURIUS™ DRUG-seq data analysis, from raw FASTQ files to QC and differential expression. 👉 Register here: eu1.hubs.ly/H0ycjph0 #Bioinformatics #DrugDiscovery #RNA-seq

Alithea Genomics would like to invite you to join us at the EPFL Latsis Symposium. 📍 Olympic Museum, Lausanne 📅 October 29–30, 2026 Register here: eu1.hubs.ly/H0y7PRw0 #SingleCell #MultiOmics #ComputationalBiology #EPFL

In this short clip from our recent Drug Discovery World webinar, Alithea Genomics co-founder and CSO Daniel Alpern explains why bringing transcriptomics to screening scale requires rethinking the workflow. #DrugDiscovery #RNAseq #HighThroughputScreening

In this practical webinar, Alexandre Coudray will guide participants through the key steps of DRUG-seq data analysis. 👉 Register here: eu1.hubs.ly/H0xTNws0 #Bioinformatics #DrugDiscovery #HighThroughputScreening

Mechanism of action is rarely captured by a handful of genes alone. It emerges from coordinated changes across biological pathways. 🎥 Watch the full recording: eu1.hubs.ly/H0xdGkT0 #DrugDiscovery #RNAseq

Combining high-content imaging with transcriptomic profiling can provide a more comprehensive view of cellular response, linking phenotypic changes to molecular mechanisms at scale. Join our talk at SBI²? #Transcriptomics #HighContentScreening #DrugDiscovery

Plant transcriptomics just got easier to scale, whether you want to run it in-house or outsource the workflow. Discover Total Plant BRB-seq kit: eu1.hubs.ly/H0wFpSD0 #RNAseq #CropScience #AgrochemicalResearch

Celebrating 6 years of Alithea Genomics 🥂 From a small team to a global provider of high-throughput transcriptomics for drug discovery, crop protection, and academic research. These 6 years have been about growth, innovation, teamwork, and impact. #transcriptomics #rnaseq

Last chance to register and join Riccardo Dainese and Maya Wilson in an exciting presentation of MERCURIUS™ 1536 DRUG-seq. eu1.hubs.ly/H0wmC0j0 #DrugDiscovery #Transcriptomics #HighThroughputScreening #DRUGseq #RNAseq #AIinDrugDiscovery #MechanismOfAction #Toxicology

Join Riccardo Dainese, co-founder and CBO of Alithea Genomics, and Maya Wilson, Senior Scientist at Arctoris, in our next webinar. eu1.hubs.ly/H0wfmcY0 #DrugDiscovery #Transcriptomics #HighThroughputScreening #DRUGseq #RNAseq #AIinDrugDiscovery #MechanismOfAction #Toxicology

MERCURIUS™ 1536 DRUG-seq brings DRUG-seq into native 1536-well workflows, so teams can generate transcriptome-wide compound-response data at a scale that matches the needs of foundational AI-models for drug-discovery. More details on our website: eu1.hubs.ly/H0w8DBS0